Ultragenyx Pharmaceutical

RARENasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.539 B

$15.62 +6.59%

Close of 22 Sept 2026

Revenue

$673.0M

#1754 by revenue

Earnings

-$575.0M

Loss-making

Shares outstanding

98,588,873

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#126AnaptysbioANAB$1.60B
#127Xeris BiopharmaXERS$1.59B
#128Ultragenyx PharmaceuticalRARE$1.54B
#129KardiganKARD$1.54B
#130OmerosOMER$1.52B

What if Ultragenyx Pharmaceutical were worth as much as…

Open the what-if tool →

Gold $30.2T

$306,667.16

Per share 19,639× higher

Bitcoin $1.74T

$17,665.84

Per share 1,131× higher

Nvidia $5.52T

$55,947.16

Per share 3,583× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Ultragenyx Pharmaceutical are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.